Premium
CYP1A2 Activity Predicts The Clozapine Steady‐State Concentration in Schizophrenic Patients
Author(s) -
Özdemir V.,
Posner P.,
Collins E.J.,
Walker S.E.,
Roy R.,
Walkes W.,
Tang B.K.,
Kennedy J.L.,
McKenzie J.,
Kalow W.
Publication year - 1999
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1016/s0009-9236(99)80230-6
Subject(s) - clozapine , cyp1a2 , pharmacology , pharmacokinetics , clinical pharmacology , medicine , schizophrenia (object oriented programming) , psychiatry , cytochrome p450 , metabolism
Clinical Pharmacology & Therapeutics (1999) 65 , 175–175; doi: